publication venue for
- Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds. 53:151971-151971. 2022
- Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study.. 51:1291-1299. 2021
- Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort. 50:915-922. 2020
- Patterns of clinical presentation in Takayasu's arteritis. 50:576-581. 2020
- How can we define low disease activity in systemic lupus erythematosus?. 48:1035-1040. 2019
- Arterial lesions in giant cell arteritis: A longitudinal study. 48:707-713. 2019
- Multivariate pattern analysis utilizing structural or functional MRI—In individuals with musculoskeletal pain and healthy controls: A systematic review. 47:418-431. 2017
- Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials. 46:151-159. 2016
- A review of the effects of statins in systemic sclerosis. 45:698-705. 2016
- Dyslipidemia in systemic lupus erythematosus: just another comorbidity?. 45:604-610. 2016
- Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. 45:475-482. 2016
- Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. 45:156-162. 2015
- Thinking outside the box—The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. 45:184-189. 2015
- Antinuclear antibody-negative systemic sclerosis. 44:680-686. 2015
- Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey. 43:666-672. 2014
- Vertebral fracture assessment-detected abdominal aortic calcification and cardiovascular disease in rheumatoid arthritis. 43:632-637. 2014
- Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? A critical appraisal. 43:521-525. 2014
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis. 41:178-186. 2011
- Campylobacter Reactive Arthritis: A Systematic Review. 37:48-55. 2007
- Bone Strength: The Whole Is Greater Than the Sum of Its Parts. 36:22-31. 2006
- The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future. 36:10-21. 2006
- Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon. 35:293-305. 2006
- Management of corticosteroid-induced osteoporosis. 29:228-251. 2000
- Corticosteroid-induced osteoporosis. 22:375-384. 1993
- Are lymphocytes a target for substance P modulation in arthritis?. 21:252-258. 1992
- Gold induced thrombocytopenia: 12 cases and a review of the literature. 16:287-293. 1987
- d-penicillamine: Chemistry and clinical use in rheumatic disease. 15:261-281. 1986
- The musculoskeletal manifestations of cystic fibrosis. 15:213-225. 1986
- The history of gold therapy in rheumatoid disease. 14:180-186. 1985